Natural Health Trends Corp.

Second-quarter revenue was $7.6 million, down 23% from $9.8 million in Q2 2025. Gross margin improved to 75.2% from 73.9%, commissions expense was 40.9% of revenue, SG&A was $3.3 million, operating loss was $643,000 versus $333,000 last year, and net loss was $451,000, or $0.05 per diluted share, versus net income of $15,000, or breakeven per diluted share, in the prior-year quarter. For the first six months of 2026, operating cash used was $2.2 million, and cash, cash equivalents and marketable securities totaled $18.6 million at June 30. Management did not provide a specific revenue or EPS outlook for next quarter or full year, but said additional savings are expected in the second half of 2026 and reiterated focus on execution, product launches, digital capabilities, and member engagement.

Chris Sharng framed the quarter as pressured by external and compliance-related disruptions, especially in China and Hong Kong, but emphasized that restructuring is improving margins and reducing expenses. He said the company remains focused on financial discipline, product innovation, digital tools, and meaningful field engagement to strengthen its competitive position as market conditions improve. His tone was cautious but constructive, reinforced by the planned 25th anniversary event in Hong Kong and the resumption of share repurchases as a sign of confidence.

Scott Davidson quantified the quarter’s decline and the offsetting cost benefits, noting revenue of $7.6 million, gross margin of 75.2%, commissions at 40.9% of revenue, SG&A of $3.3 million, operating loss of $643,000, and net loss of $451,000, or $0.05 per share. He said the restructuring delivered improved margin and reduced operating expenses, with year-to-date savings of more than $600,000 and more expected in the second half. On liquidity, he said cash, cash equivalents and marketable securities were $18.6 million at June 30, down from $28.9 million at year-end, mainly because of share repurchases and dividends, and operating cash use improved to $2.2 million for the first half versus $5.2 million last year.

There was no analyst Q&A in the transcript, so no specific investor concerns or management rebuttals were covered. The main issues management did address were China consumer caution, regulatory uncertainty, and conduct by certain members in Hong Kong that disrupted business and hurt second-quarter results. They responded by emphasizing restructuring benefits, tighter execution, and continued investment in engagement and product innovation.